Rhenium (186-Re) obisbemeda
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Rhenium (186-Re) obisbemeda
- DrugBank Accession Number
- DB18523
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 671.8
Monoisotopic: 671.20260831 - Chemical Formula
- C20H45N4OReS4
- Synonyms
- Rhenium (186re) obisbemeda
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- O5L8T4LD4L
- CAS number
- 644961-22-8
- InChI Key
- WGNFIJYHYDDFMP-LDYDCSBASA-K
- InChI
- InChI=1S/2C10H24N2S2.O.Re/c2*1-3-11(4-2)5-6-12(7-9-13)8-10-14;;/h2*13-14H,3-10H2,1-2H3;;/q;;;+3/p-3/i;;;1+0
- IUPAC Name
- (2-{[2-(diethylamino)ethyl](2-sulfanidylethyl)amino}ethyl)sulfanide; (2-{[2-(diethylamino)ethyl](2-sulfanylethyl)amino}ethyl)sulfanide; oxo(186Re)rheniumtris(ylium)
- SMILES
- O=[186Re+3].CCN(CC)CCN(CCS)CC[S-].CCN(CC)CCN(CC[S-])CC[S-]
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.95 Chemaxon pKa (Strongest Acidic) 8.07 Chemaxon pKa (Strongest Basic) 8.59 Chemaxon Physiological Charge 3 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 6.48 Å2 Chemaxon Rotatable Bond Count 18 Chemaxon Refractivity 73.2 m3·mol-1 Chemaxon Polarizability 28.81 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 28, 2023 15:31 / Updated at February 05, 2024 00:29